Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers - PubMed (original) (raw)
Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers
Jian Zhang et al. Cancer Res. 2006.
Free article
Abstract
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited cancer predisposition syndrome caused by germ line mutations in DNA mismatch repair genes, predominantly MLH1 and MSH2, with large genomic rearrangements accounting for 5% to 20% of all mutations. Although crucial to the understanding of cancer initiation, little is known about the second, somatic hit in HNPCC tumorigenesis, commonly referred to as loss of heterozygosity. Here, we applied a recently developed method, multiplex ligation-dependent probe amplification, to study MLH1/MSH2 copy number changes in 16 unrelated Swiss HNPCC patients, whose cancers displayed microsatellite instability and loss of MLH1 or MSH2 expression, but in whom no germ line mutation could be detected by conventional screening. The aims of the study were (a) to determine the proportion of large genomic rearrangements among Swiss MLH1/MSH2 mutation carriers and (b) to investigate the frequency and nature of loss of heterozygosity as a second, somatic event, in tumors from MLH1/MSH2 germ line deletion carriers. Large genomic deletions were found to account for 4.3% and 10.7% of MLH1 and MSH2 mutations, respectively. Multiplex ligation-dependent probe amplification analysis of 18 cancer specimens from two independent sets of Swiss and Finnish MLH1/MSH2 deletion carriers revealed that somatic mutations identical to the ones in the germ line occur frequently in colorectal cancers (6 of 11; 55%) and are also present in extracolonic HNPCC-associated tumors. Chromosome-specific marker analysis implies that loss of the wild-type allele predominantly occurs through locus-restricted recombinational events, i.e., gene conversion, rather than mitotic recombination or deletion of the respective gene locus. (Cancer Res 2006; (66)2: 659-64).
Similar articles
- Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.
Zavodna K, Krivulcik T, Bujalkova MG, Slamka T, Martinicky D, Ilencikova D, Bartosova Z. Zavodna K, et al. BMC Cancer. 2009 Nov 20;9:405. doi: 10.1186/1471-2407-9-405. BMC Cancer. 2009. PMID: 19930554 Free PMC article. - Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S, Görgens H, Plaschke J, Hoehl R, Krüger S, Engel C, Saeger HD, Schackert HK. Pistorius S, et al. Cancer Lett. 2007 Apr 8;248(1):89-95. doi: 10.1016/j.canlet.2006.06.002. Epub 2006 Jul 11. Cancer Lett. 2007. PMID: 16837128 - [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L, Tiszlavicz L, Takács R, Baradnay G, Lonovics J, Cserni G, Závodná K, Bartosova Z. Czakó L, et al. Orv Hetil. 2005 May 15;146(20):1009-16. Orv Hetil. 2005. PMID: 15945244 Hungarian. - Genetics of hereditary nonpolyposis colorectal cancer.
Akrami SM. Akrami SM. Arch Iran Med. 2006 Oct;9(4):381-9. Arch Iran Med. 2006. PMID: 17061614 Review. - Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
Hitchins MP, Ward RL. Hitchins MP, et al. J Med Genet. 2009 Dec;46(12):793-802. doi: 10.1136/jmg.2009.068122. Epub 2009 Jun 29. J Med Genet. 2009. PMID: 19564652 Review.
Cited by
- Anticipation in lynch syndrome: where we are where we go.
Bozzao C, Lastella P, Stella A. Bozzao C, et al. Curr Genomics. 2011 Nov;12(7):451-65. doi: 10.2174/138920211797904070. Curr Genomics. 2011. PMID: 22547953 Free PMC article. - Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas.
Porkka NK, Olkinuora A, Kuopio T, Ahtiainen M, Eldfors S, Almusa H, Mecklin JP, Peltomäki P. Porkka NK, et al. Oncotarget. 2020 Apr 7;11(14):1244-1256. doi: 10.18632/oncotarget.27538. eCollection 2020 Apr 7. Oncotarget. 2020. PMID: 32292574 Free PMC article. - Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters.
Hashmi AA, Mudassir G, Hashmi RN, Irfan M, Asif H, Khan EY, Abu Bakar SM, Faridi N. Hashmi AA, et al. Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2601-2606. doi: 10.31557/APJCP.2019.20.9.2601. Asian Pac J Cancer Prev. 2019. PMID: 31554352 Free PMC article. - Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.
Zavodna K, Krivulcik T, Bujalkova MG, Slamka T, Martinicky D, Ilencikova D, Bartosova Z. Zavodna K, et al. BMC Cancer. 2009 Nov 20;9:405. doi: 10.1186/1471-2407-9-405. BMC Cancer. 2009. PMID: 19930554 Free PMC article. - MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
Morales-Burgos A, Sánchez JL, Figueroa LD, De Jesús-Monge WE, Cruz-Correa MR, González-Keelan C, Nazario CM. Morales-Burgos A, et al. P R Health Sci J. 2008 Dec;27(4):322-7. P R Health Sci J. 2008. PMID: 19069357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources